Hormonal Control of Plasminogen Activator in Rat Mammary Tumors
Author Information
Author(s): K. Inada, J. Yamashita, S. Matsuo, Y. Nakashima, S. Yamashita, M. Ogawa
Primary Institution: Kumamoto University Medical School
Hypothesis
Does oestrogen regulate plasminogen activator activity in DMBA-induced rat mammary carcinomas?
Conclusion
The study concludes that hormonal regulation of plasminogen activator activity is specific to malignant DMBA-induced rat mammary tumors.
Supporting Evidence
- Oestrogen was found to regulate plasminogen activator activity in DMBA-induced carcinomas.
- The study showed that hormonal treatment patterns significantly affected tumor development.
- In vivo experiments demonstrated that oophorectomy and oestrogen administration influenced plasminogen activator activity.
Takeaway
This study shows that hormones can change how cancer cells behave, specifically how they produce a certain enzyme that helps tumors grow.
Methodology
The study involved in vivo and in vitro experiments on DMBA-induced rat mammary tumors, examining the effects of hormonal treatments on plasminogen activator activity.
Limitations
The study may not fully represent human breast cancer due to species differences.
Participant Demographics
Newborn female Sprague-Dawley rats were used in the study.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website